Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Smallpox Vaccine Immunization Policy Should Be Subject Of Hearings – Frist

Executive Summary

Congressional hearings on a smallpox vaccine immunization policy would be timely, Sen. Bill Frist (R-Tenn.) said March 29 in response to the donation of over 85 mil. doses of vaccine by Aventis

You may also be interested in...



Anthrax Vaccine Timetable Is Reasonable, GAO Finds; Aventis Protest Denied

HHS' next-generation anthrax vaccine development deadlines are reasonable, the General Accounting Office said in a rejection of an Aventis-Pasteur protest

Anthrax Vaccine Timetable Is Reasonable, GAO Finds; Aventis Protest Denied

HHS' next-generation anthrax vaccine development deadlines are reasonable, the General Accounting Office said in a rejection of an Aventis-Pasteur protest

Next-Gen Smallpox, Anthrax Vaccines To Be First Use Of Animal Efficacy

A next-generation smallpox vaccine is expected to be the first product licensed under FDA's animal efficacy rule, HHS Office of the Assistant Secretary for Public Health Emergency Preparedness Senior Advisor Philip Russell, MD, said Aug. 28

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS039592

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel